Daily plecanatide boosts bowel movement in chronic idiopathic constipation, IBS-C

CHARLOTTE, N.C. — Once daily plecanatide effectively relieved symptoms in patients of varying age with chronic idiopathic constipation and irritable bowel syndrome-constipation, according to a poster at the ACG Annual Scientific Meeting.“This analysis was conducted to further assess the potential impact of age on the efficacy and safety of plecanatide in an analysis of adults with [chronic idiopathic constipation] or IBS-C,” Kyle Staller, MD, director of the Gastrointestinal Motility Laboratory at Massachusetts General and assistant professor of medicine at Harvard MedicalRead More